Recently, Dr. Sun Yimin, President of CapitalBiotech, along with Dr. Li Yanze, Assistant President, visited Kyrgyzstan to hold a working meeting with officials from the Chinese Embassy in Kyrgyzstan. During the same period, at the 19th MedExpo Kyrgyzstan, Kanatbek Temirbekovich Bekboyev, Minister of Health of Kyrgyzstan, visited the CapitalBiotech’ booth and held in-depth discussions with Dr. Sun and his delegation, further advancing the construction of the Kyrgyzstan National Precision Medicine Center.
As the joint construction of the Belt and Road Initiative enters a new stage of high-quality development, CapitalBiotech is committed to seizing this opportunity and working closely with Kyrgyz partners to steadfastly promote high-quality cooperation under the BRI framework.
Introduction to Microarray Chip Analysis TechnologyApril 10, 2024Microarray chip analysis technology, as an important innovation in the field of modern biotechnology, plays an increasingly important role in the fields of genomics, proteomics, and disease diagnosis ...view
Application of Genome Sequencing Technology in Newborn ScreeningNovember 13, 2024Newborn screening is a successful public health initiative that prevents diseases and reduces mortality through early diagnosis and disease management. In the era of precision medicine, the expansion ...view
Microarray Chips and Microarray AnalysisJanuary 20, 2023Microarray analysis is often involved in the fabrication and application of microarray chips. Unlike DNA sequencing and genotyping, the analytes for microarray gene expression analysis are messenger R...view
Which is the Best Method for HLA Typing?March 11, 2024In the realm of immunogenetics, the significance of Human Leukocyte Antigen (HLA) typing cannot be overstated. It plays a pivotal role in various medical and research applications, including organ tra...view